Scinai Immunotherapeutics Ltd.

SCNI | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.91

+$0.22 (+13.02%)

At close: Sep 22, 2026, 4:00 PM ET

$1.73

-$0.18 (-9.42%)

After-hours: Sep 22, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+13.02%

(1D)

Rating

Updated: Aug 22, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $987.35K

1D Range

1.57 1.92

52W Range

1.43 16.30

Valuation (TTM)

PE 0

PB 0.07

EV/EBITDA -0.24

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -862.0%

SBC Adj. FCF Yield -865.9%

SBC Impact -0.4%

Margins

Gross Margin -252.4%

Operating Margin -563.9%

FCF Margin -504.2%

Growth (CAGR)

Revenue 3Y | 5Y 58.1% | 69.4%

Dil EPS 3Y | 5Y 74.0% | 78.8%

FCF 3Y | 5Y -4.5% | 8.3%

Returns

ROA -15.4%

ROE -26.6%

ROIC -55.0%

Financial Health

Net Cash

$2.2M

Current Ratio 1.56

Interest Coverage -39.09

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary obje...

Sector Healthcare

Industry Biotechnology

Employees 45

IPO Date May 10, 2015

Website www.scinai.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞